Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Emergency Medicine Management of Sickle Cell Disease Complications: An Evidence-Based Update
source: The Journal of Emergency Medicine
year: 2016
authors: Simon E, Long B, Koyfman A
summary/abstract:BACKGROUND:
Sickle cell disease (SCD) affects approximately 100,000 individuals in the United States. Due to alterations in the structural conformation of hemoglobin molecules under deoxygenated conditions, patients with SCD are predisposed to numerous sequelae, many of which require acute intervention.
OBJECTIVE:
Our aim was to provide emergency physicians with an evidence-based update regarding the diagnosis and management of SCD complications.
DISCUSSION:
SCD patients experience significant morbidity and mortality secondary to cerebrovascular accident, acute chest syndrome, acute vaso-occlusive pain crises, SCD-related multi-organ failure, cholecystitis, acute intrahepatic cholestasis, acute sickle hepatic crisis, acute hepatic sequestration, priapism, and renal disease. Emergency physicians must recognize acute manifestations of SCD in order to deliver timely management and determine patient disposition.
CONCLUSIONS:
A comprehensive review of the emergency department management of acute SCD complications is provided. Comprehensive understanding of these aspects of SCD can assist physicians in expediting patient evaluation and treatment, thus decreasing the morbidity and mortality associated with this hemoglobinopathy.
DOI: 10.1016/j.jemermed.2016.05.042
read more full text
+myBinderRelated Content
-
Losartan for the nephropathy of sickle cell anemia: A phase-2, multicenter trialNephropathy is a common and progressive ...
-
Patterns of opioid use in sickle cell diseasePain, the hallmark complication of sickl...
-
Study challenges view that sickle cell trait increases mortality riskSurprising findings from a study of heal...
-
Ward Hagar, MDDr. Hagar is the Director of Adult Sickl...
-
Cindy Neunert, MDCindy Neunert, MD is a practicing pediat...
-
Webinar Series: Sickle Cell Science: Path to Progress – Bone Marrow Transplants, Other Therapies, and Sickle C...To commemorate Sickle Cell Awareness Mon...
-
Gene-Therapy Company Crispr Drops as FDA Puts Trial on HoldCrispr Therapeutics AG plunged after the...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.